Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9679910 | 0.80 | HTR2C (0.42) | HTR2CHTR2AHTR2BL3MBTL1SLC6A2 | |
| SCHEMBL19798400 | 0.79 | KDM1A (0.56) | SLC6A2SLC6A4KMT2A | |
| SCHEMBL641032 | 0.79 | HTR2C (0.43) | HTR2CMEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL10012213 | 0.77 | SLC6A2 (0.32) | SLC6A2SLC6A4 | |
| SCHEMBL8796050 | 0.76 | CYP3A4 (0.35) | MEN1KMT2AALDH1A1 | |
| SCHEMBL16516779 | 0.76 | CYP3A4 (0.37) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL645528 | 0.76 | ALDH1A1 (0.45) | MEN1KMT2AALDH1A1TDP1 | |
| SCHEMBL28318181 | 0.75 | KDM1A (0.47) | HTR2CHTR2AHTR2BSLC6A2SLC6A4 | |
| SCHEMBL9721529 | 0.75 | HTR2C (0.42) | HTR2CHTR2AHTR2BSLC6A2SLC6A4 | |
| SCHEMBL12897657 | 0.74 | DRD2 (0.53) | HTR2CMEN1KMT2AALDH1A1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4460726-A1 | NONLINEAR OPTICAL CHROMOPHORES HAVING SHORT-CHAIN BRIDGE STRUCTURES, LOW OPTICAL LOSS MATERIALS CONTAINING THE SAME, AND METHODS FOR PREPARING THE SAME | Lightwave Logic, Inc. (US) | 2024-11-13 | — | — | EP | claimed |
| WO-2023132934-A1 | NONLINEAR OPTICAL CHROMOPHORES HAVING SHORT-CHAIN BRIDGE STRUCTURES, LOW OPTICAL LOSS MATERIALS CONTAINING THE SAME, AND METHODS FOR PREPARING THE SAME | LIGHTWAVE LOGIC, INC. (US) | 2023-07-13 | — | — | WO | claimed |
| US-20230212399-A1 | Nonlinear Optical Chromophores Having Short-Chain Bridge Structures, Low Optical Loss Materials Containing the Same, and Methods for Preparing the Same | LIGHTWAVE LOGIC, INC. (US) | 2023-07-06 | — | — | US | claimed |
| US-12565587-B2 | Nonlinear optical chromophores having short-chain bridge structures, low optical loss materials containing the same, and methods for preparing the same | LIGHTWAVE LOGIC, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| EP-4460726-A1 | NONLINEAR OPTICAL CHROMOPHORES HAVING SHORT-CHAIN BRIDGE STRUCTURES, LOW OPTICAL LOSS MATERIALS CONTAINING THE SAME, AND METHODS FOR PREPARING THE SAME | Lightwave Logic, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| WO-2023132934-A1 | NONLINEAR OPTICAL CHROMOPHORES HAVING SHORT-CHAIN BRIDGE STRUCTURES, LOW OPTICAL LOSS MATERIALS CONTAINING THE SAME, AND METHODS FOR PREPARING THE SAME | LIGHTWAVE LOGIC, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20230212399-A1 | Nonlinear Optical Chromophores Having Short-Chain Bridge Structures, Low Optical Loss Materials Containing the Same, and Methods for Preparing the Same | LIGHTWAVE LOGIC, INC. (US) | 2023-07-06 | — | — | US | disclosed |
| CN-112441930-A | Compound, light-emitting device, light-emitting apparatus, electronic device, and lighting apparatus | 株式会社半导体能源研究所 | 2021-03-05 | — | — | CN | disclosed |
| EP-1305306-A2 | 2-ADAMANTYLETHYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RESEARCH LIMITED (GB) | 2003-05-02 | — | — | EP | disclosed |
| WO-2002008219-A2 | 2-ADAMANTYLETHYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION | VERNALIS RESEARCH LIMITED (GB) | 2002-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565587-B2 | Nonlinear optical chromophores having short-chain bridge structures, low optical loss materials containing the same, and methods for preparing the same | CRY2, GJB2, CYBA | HTR2C 2399/4885HTR2A 1950/4885HTR2B 1529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.